Home » Newsletters » BioWorld

BioWorld

Dec. 4, 1991

View Archived Issues

BLOCKED RICIN TARGETS CANCER

MEDIMMUNE, MERCK COMPLETE DEAL

GENENTECH LICENSES CAMBRIDGE'S HIV PROTEIN

CAL BIO TO TAKE $6 MILLION CHARGE

ITALY APPROVES BTGC's GROWTH HORMONE

GENSIA SUBSIDIARY GETS TWO ANDAs

IVAX RAISES $110.5 MILLION IN PRIVATE OFFERING

FIELD STUDY GUIDELINES DUE

MARKER GENE REMOVED FROM ALTERED PLANTS

NICOTINE PATCH BATTLE HEATS UP

COURT DEALS SETBACK TO KODAK ON PCR

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...